Aditxt, Inc. - Common Stock (ADTX)

Aditxt Inc is a biotech company focused on enhancing the immune system through innovative technologies designed to promote immune tolerance

The company seeks to develop therapies that can help manage and treat immune-related diseases by leveraging its proprietary platform to create customized solutions. Aditxt's research and development efforts aim to address a range of immunological disorders, potentially transforming the landscape of immunotherapy and improving patient outcomes through better immune system management.